
    
      This is a multinational, multicenter, two-part, Phase 2 study that will evaluate the
      tolerability, safety, and efficacy of KLâ‚„Surfactant in adult ARDS patients when administered
      by sequential bronchoscopic lavage into each of the 19 bronchopulmonary segments of the lung
      and as a bolus instillation into each lung.
    
  